Jasper Therapeutics (JSPR) Stock Highlights

21.57 | +0.19%

2024-12-21 05:45:45

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Statistics

Range Today

21 22.2

Volume Today 206.1K

Range 1 Year

5 31.01

Volume 1 Year 43.63M

Range 3 Year

3.86 98

Volume 3 Year 78.89M

Range 10 Year

3.86 188.8

Volume 10 Year 98.86M

Highlights

Market Capitalization 370.53M (small)

Floating Shares 9.39M

Current Price 21.57

Price To Earnings -3.99

Price To Book 3.49

Earnings Per Share -5.51

Payout Ratio 0%

Performance

Latest +0.19%

1 Month +5.32%

3 Months -9.71%

6 Months -6.18%

1 Year +299.44%

3 Years -75.57%

5 Years -78.03%

10 Years -78.03%

Benchmarks

Market Capitalization

196 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

170 / 368

Free Cashflow

166 / 352

Performance 5 years

223 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.